High Pointe Capital Management’s Bio-Techne TECH Stock Holding History

High Pointe Capital Management’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-28,400	Closed	-$639K	–	123
2015 Q4	$639K	Sell	28,400 -73,920	-72%	-$1.69M	0.31%	118
2015 Q3	$2.37M	Buy	102,320 +22,360	+28%	+$561K	1.11%	19
2015 Q2	$1.97M	Buy	79,960 +3,920	+5%	+$97.9K	0.7%	53
2015 Q1	$1.91M	Buy	76,040 +32,360	+74%	+$769K	0.68%	58
2014 Q4	$1.01M	Buy	+43,680	New	+$1,000K	0.45%	102

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

MPI

Mairs & Power Inc St Paul, Minnesota $10.9B AUM 27.5% 1-Year Est. Return

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

High Pointe Capital Management's TECH Position: Q1 2016 in Review

High Pointe Capital Management sold out of Bio-Techne (TECH) in Q1 2016, closing a stake of 28,400 shares — an estimated $639K sold.

High Pointe Capital Management first reported a position in TECH in Q4 2014 and held it in 5 quarters. The position peaked at $2.37M in Q3 2015. 257 funds tracked by Wall St. Rank hold TECH as of Q1 2016.

High Pointe Capital Management reported no remaining Bio-Techne position as of Q1 2016 after selling out during the quarter.
High Pointe Capital Management sold 28,400 Bio-Techne shares in Q1 2016, an estimated $639K.
High Pointe Capital Management first reported a position in Bio-Techne in Q4 2014 and held it in 5 quarters.
High Pointe Capital Management's Bio-Techne position peaked at $2.37M in Q3 2015.
257 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2016.

Based on High Pointe Capital Management's 13F filing for Q1 2016, filed 5 May 2016.